Abstract:BackgroundDistinguishing between acute presentations of osteomyelitis (OM) and vaso-occlusive crisis (VOC) bone infarction in children with sickle cell disease (SCD) remains challenging for clinicians, particularly in culture-negative cases. We examined the combined role of ultrasound scan (USS), C - reactive protein and White blood counts (WCC) in aiding early diagnosis in children with SCD presenting acutely with non-specific symptoms such as bone pain, fever or swelling which are common in acute osteomyelit… Show more
“…Osteomyelitis can present as an acute or chronic inflammatory destruction of the bone and is characterized by progressive destruction of infected bone and recruitment of osteocytes to the infection sites. These sites include femur, humerus, vertebra, ribs, and sternum (4,5), although any bone may be infected (3,5,6). Osteomyelitis is multifactorial in nature and is influenced by local factors relating to bone lesion and type of infectious microorganism (5,7), together with an inherited predisposition and immunological dysfunction (3,8,9).…”
mentioning
confidence: 99%
“…Distinguishing the acute presentation of osteomyelitis from VOC relies on clinical assessment (fever and pain on admission, swelling of affected limb, and painful sites) and radiological findings (ultrasound scans, magnetic resonance imaging [MRI]), in combination with elevated C-reactive protein (CRP) and white blood cell (WBC) counts (5,10). Distinct cytokine profiles were reported during early (1 to 4 months) and late (5 to 12 months) osteomyelitis episodes; the early-episode profiles are highlighted by an increased frequency of high tumor necrosis factor alpha (TNF-␣) and interleukin-4 (IL-4) producers, while the late-episode profiles are exemplified by increased frequencies of IL-10, IL-6, and IL-2 producers (11).…”
Osteomyelitis is a significant complication of sickle cell disease (SCD), and several factors contribute to its pathogenesis, including altered expression of proinflammatory and anti-inflammatory cytokines. In view of the role of interleukin-10 (IL-10) as an anti-inflammatory cytokine, we tested the notion that SCD osteomyelitis is associated with a reduction in IL-10 secretion and, hence, precipitation of a proinflammatory state. Study subjects comprised 52 SCD patients with confirmed diagnosis of osteomyelitis and 165 age-and gender-matched SCD patients with negative histories of osteomyelitis. Results obtained showed that IL-10 serum levels in SCD osteomyelitis patients were significantly lower than those of control SCD patients. Receiver operating characteristic (ROC) analysis demonstrated that altered IL-10 serum levels predicted the development of osteomyelitis, and the mean area under ROC curves of IL-10 was 0.810 among SCD patients with osteomyelitis. A systematic shift in IL-10 serum levels toward lower values was seen in osteomyelitis cases, with an increased osteomyelitis risk associated with decreased IL-10 levels. Multivariate logistic regression analyses confirmed the independent association of reduced IL-10 with osteomyelitis after controlling for sickle hemoglobin (HbS), fetal hemoglobin (HbF), platelet count, and white blood cell (WBC) count. These data support the strong association of decreased IL-10 levels with osteomyelitis, thereby supporting a role for IL-10 in osteomyelitis follow-up.
“…Osteomyelitis can present as an acute or chronic inflammatory destruction of the bone and is characterized by progressive destruction of infected bone and recruitment of osteocytes to the infection sites. These sites include femur, humerus, vertebra, ribs, and sternum (4,5), although any bone may be infected (3,5,6). Osteomyelitis is multifactorial in nature and is influenced by local factors relating to bone lesion and type of infectious microorganism (5,7), together with an inherited predisposition and immunological dysfunction (3,8,9).…”
mentioning
confidence: 99%
“…Distinguishing the acute presentation of osteomyelitis from VOC relies on clinical assessment (fever and pain on admission, swelling of affected limb, and painful sites) and radiological findings (ultrasound scans, magnetic resonance imaging [MRI]), in combination with elevated C-reactive protein (CRP) and white blood cell (WBC) counts (5,10). Distinct cytokine profiles were reported during early (1 to 4 months) and late (5 to 12 months) osteomyelitis episodes; the early-episode profiles are highlighted by an increased frequency of high tumor necrosis factor alpha (TNF-␣) and interleukin-4 (IL-4) producers, while the late-episode profiles are exemplified by increased frequencies of IL-10, IL-6, and IL-2 producers (11).…”
Osteomyelitis is a significant complication of sickle cell disease (SCD), and several factors contribute to its pathogenesis, including altered expression of proinflammatory and anti-inflammatory cytokines. In view of the role of interleukin-10 (IL-10) as an anti-inflammatory cytokine, we tested the notion that SCD osteomyelitis is associated with a reduction in IL-10 secretion and, hence, precipitation of a proinflammatory state. Study subjects comprised 52 SCD patients with confirmed diagnosis of osteomyelitis and 165 age-and gender-matched SCD patients with negative histories of osteomyelitis. Results obtained showed that IL-10 serum levels in SCD osteomyelitis patients were significantly lower than those of control SCD patients. Receiver operating characteristic (ROC) analysis demonstrated that altered IL-10 serum levels predicted the development of osteomyelitis, and the mean area under ROC curves of IL-10 was 0.810 among SCD patients with osteomyelitis. A systematic shift in IL-10 serum levels toward lower values was seen in osteomyelitis cases, with an increased osteomyelitis risk associated with decreased IL-10 levels. Multivariate logistic regression analyses confirmed the independent association of reduced IL-10 with osteomyelitis after controlling for sickle hemoglobin (HbS), fetal hemoglobin (HbF), platelet count, and white blood cell (WBC) count. These data support the strong association of decreased IL-10 levels with osteomyelitis, thereby supporting a role for IL-10 in osteomyelitis follow-up.
“…Bone scans are of limited utility [5,8]. Some studies report high reliability of US for the differentiation of bone infarct versus osteomyelitis in children with SCD because of US findings of soft-tissue abnormalities and subperiosteal collection [6,12,13]. However in our US experience and based on the results of this MRI study, soft-tissue changes and subperiosteal fluid collection occur in both processes, so these cannot accurately distinguish between the two.…”
Section: Discussionmentioning
confidence: 76%
“…Both diagnoses also result in similar laboratory abnormalities including leukocytosis and elevated inflammatory markers (C-reactive protein and erythrocyte sedimentation rate) [4,6,7]. The gold standard for the diagnosis of osteomyelitis is a positive culture from a sampling of bone, synovial fluid or blood.…”
Section: Introductionmentioning
confidence: 99%
“…Lack of microbiological data does not exclude the diagnosis of osteomyelitis [4,7]. Thus most experts suggest the integration of clinical symptoms, laboratory findings and imaging studies for the differentiation of acute bone infarct and acute osteomyelitis in children with SCD [4,6,7]. It is important to realize that a bone infarct is 50 times more common than osteomyelitis in children with SCD [4,5].…”
The bone marrow signal intensity on unenhanced T1-W fat-saturated MR images is not a reliable criterion to differentiate bone infarcts from osteomyelitis in children.
Background
Patients with sickle cell disease (SCD) are at increased risk for osteomyelitis (OM). Diagnosis of OM in SCD is challenging as the clinical presentation is similar to a vasoocclusive crisis (VOC) with no diagnostic gold standard. We report characteristics and outcomes of OM in SCD patients treated at our center over 10‐year period.
Design/Method
We conducted a retrospective analysis of patients with SCD who were treated for OM at our center over a 10‐year period (2006‐2016). Cases were identified utilizing radiology data mining software. Radiology reports and medical charts of potential OM cases were reviewed.
Results
Twenty‐eight children with SCD were treated for OM at our institution. Patients treated for OM were largely similar to patients treated for a VOC. However, patients treated for OM had significantly higher C‐reactive protein (10 mg/dL vs 5.58 mg/dL, P = 0.03) and erythrocyte sedimentation rate (60 mm/h vs 47 mm/h, P = 0.02). Magnetic resonance imaging (MRI) findings were consistent with OM in 18 (64%) patients and indeterminate in the remaining. Based on clinical, laboratory, and radiological findings, the diagnosis of OM was considered confirmed in 3 patients, probable in 6 patients, and presumed in 19 patients. Nontyphoidal Salmonella was isolated from cultures in 9 (32%) patients, while no organism was identified in 19 (67%) patients. All patients were treated with antibiotics. Six patients (21%) required surgical interventions.
Conclusions
OM continues to pose diagnostic challenges. Most patients are treated for OM without definitive confirmation. Nontyphoidal Salmonella was the only organism identified in our cohort.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.